In a recently revealed email, the DEA is looking to consider Delta-8 THC products federally illegal if they are synthesized from CBD.
The Drug Enforcement Administration (DEA) is pondering how to handle Delta-8 tetrahydrocannabinol (THC) products. An attorney recently discovered an email from a top official that discussed the DEA’s views on Delta-8 THC (1). The email mentioned that the agency is against Delta-8 THC when it is synthesized from cannabidiol (CBD) and consider it federally illegal.
Delta-8 THC has exploded in popularity in the cannabis industry. It has been considered to be an intoxicating cannabinoid because if its naturally extracted derivatives similar to CBD which has led it to being the focus of several lawsuits battling state policies that have banned it. Shane Pennington, an attorney, previously posted on his Substack “On Drugs” that while he was looking over the various lawasuits, he discovered a 2021 letter from DEA Drug & Chemical Evaluation Section Chief Terrence Boos that mentioned the DEA’s interpretation of the cannabinoid.
“Arriving at delta-8-THC by a chemical reaction starting from CBD makes the delta-8-THC synthetic and therefore, not exempted by the [Agriculture Improvement Act],” Boos wrote, referring back to the 2018 Farm Bill, that federally legalized hemp (1). “Any quantity of delta-8-THC obtained by chemical means is a controlled substance.”
The DEA held their 2023 Supply Chain Conference in May 2023 and stated that synthetic cannabinoids were banned. Boos added that the agency is working on establishing a final ruling on the cannabinoids to formally clarify the policy which was recommended by the US Department of Health and Human Services (1).
In February 2023, Boos informed an attorney that minor cannabinoids delta-8 THC-O and delta-9 THC-O were illegal due to the fact that they are only able to be produced synthetically and not naturally.
Even with the DEA’s opinions on synthetic cannabinoids, there still exists a strong market for products like delta-8 THC. Various states have followed by banning the cannabinoid, among others, in their states. The Food and Drug Administration has mostly sent warning letters to companies that were labeled ‘problematic’. Without a formal policy, there is no enforcement or regulation of delta-8 THC and other cannabinoid products.
Reference
Ep 27: Tracking Strains in Diverse Landscapes
July 2nd 2025In this latest installment of Noid Knowledge, we are joined by Daniela Vergara, PhD, Hemp Specialist at the Cornell Cooperative Extension, and Anna Schwabe, PhD, Associate Lecture Professor at the University of Colorado, discussing the evolution of cannabis cultivation and the need for regional climate data. Their recent project, funded by the Agricultural Genomics Foundation, studies 10 cannabis varieties grown by farmers in different regions, specifically plant characteristics, soil type, and harvest metrics. They aim to understand how environmental factors affect cannabis yield and quality, providing actionable insights for farmers and breeders.
Ep 26: Innovations in Drying and Curing to Protect Flower Quality
May 27th 2025In this latest installment of Noid Knowledge, we are joined by Dr. Allison Justice, Founder and CEO of the Hemp Mine, and David Sandelman COO, CTO & Co-Founder of Cannatrol. Here, Allison and David discuss innovations in cannabis drying and curing, focusing on the Cannatrol technology which controls vapor pressure, preserving trichome integrity, and flower quality. Additionally, Allison shares how the Cannabis Research Center and Coalition (CRC) is transition to an open-source model to support cultivators, researchers, and home growers.